BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1389475)

  • 1. Screening of new anticancer agents in vitro using panels of human cell lines derived from non-seminomatous germ cell tumours and transitional cell carcinomas of the bladder.
    Masters JR; Jenkins WE; Shoemaker RH
    Eur J Cancer; 1992; 28A(10):1617-22. PubMed ID: 1389475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide.
    Pera MF; Köberle B; Masters JR
    Br J Cancer; 1995 May; 71(5):904-6. PubMed ID: 7734313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivities to gamma radiation of human bladder and testicular tumour cell lines.
    Parris CN; Arlett CF; Lehmann AR; Green MH; Masters JR
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):599-608. PubMed ID: 2832339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs.
    Masters JR; Osborne EJ; Walker MC; Parris CN
    Int J Cancer; 1993 Jan; 53(2):340-6. PubMed ID: 8425772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair capacity and cisplatin sensitivity of human testis tumour cells.
    Köberle B; Grimaldi KA; Sunters A; Hartley JA; Kelland LR; Masters JR
    Int J Cancer; 1997 Mar; 70(5):551-5. PubMed ID: 9052754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.
    Hepburn PJ; Oliver RT; Riley PA; Hill BT; Masters JR
    Urol Res; 1985; 13(1):27-34. PubMed ID: 4039488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.
    Louie KG; Hamilton TC; Shoemaker RH; Young RC; Ozols RF
    Invest New Drugs; 1992 Jul; 10(2):73-8. PubMed ID: 1500268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer drug activity in human bladder tumor cell lines.
    Niell HB; Webster KC; Smith EE
    Cancer; 1985 Sep; 56(5):1039-44. PubMed ID: 4016694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.
    Masters JR; Thomas R; Hall AG; Hogarth L; Matheson EC; Cattan AR; Lohrer H
    Eur J Cancer; 1996 Jun; 32A(7):1248-53. PubMed ID: 8758261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.
    Tessmann JW; Buss J; Begnini KR; Berneira LM; Paula FR; de Pereira CMP; Collares T; Seixas FK
    Biomed Pharmacother; 2017 Oct; 94():37-46. PubMed ID: 28750358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    Walker MC; Parris CN; Masters JR
    J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.
    Walker MC; Masters JR; Margison GP
    Br J Cancer; 1992 Nov; 66(5):840-3. PubMed ID: 1419626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assays for new drug screening: comparison of a thymidine incorporation assay with the human tumor colony-forming assay.
    Hildebrand-Zanki SU; Kern DH
    Int J Cell Cloning; 1987 Sep; 5(5):421-31. PubMed ID: 3624922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
    Nouri AM; Symes MO
    Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
    Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
    J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
    Xiao Z; Mak A; Koch K; Moore RB
    BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pH on the in vitro colony forming ability of transitional cell carcinoma cells treated with various chemotherapeutic agents: implications for in vivo therapy.
    Tarkington M; Sommers CL; Gelmann EP; Tefft MC; Lynch JH
    J Urol; 1992 Feb; 147(2):511-3. PubMed ID: 1732633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours.
    Jonsson B; Liminga G; Csoka K; Fridborg H; Dhar S; Nygren P; Larsson R
    Eur J Cancer; 1996 May; 32A(5):883-7. PubMed ID: 9081371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid in vitro assay for predicting thermochemosensitivity of human cancer: comparison with clonogenic assay.
    Yamada K; Neumann HA; Fiebig HH; Engelhardt R; Tokita H
    Recent Results Cancer Res; 1988; 107():177-83. PubMed ID: 3375549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
    Carmichael J; Mitchell JB; DeGraff WG; Gamson J; Gazdar AF; Johnson BE; Glatstein E; Minna JD
    Br J Cancer; 1988 Jun; 57(6):540-7. PubMed ID: 2841961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.